Detalhe da pesquisa
1.
A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status.
Br J Clin Pharmacol
; 90(1): 135-145, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793249
2.
Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis.
J Neurol Neurosurg Psychiatry
; 94(2): 113-120, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096664
3.
Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia.
J Neurol Neurosurg Psychiatry
; 94(10): 863-870, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221053
4.
Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice.
J Clin Psychopharmacol
; 43(2): 131-138, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735578
5.
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring.
Br J Clin Pharmacol
; 89(7): 2316-2321, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791792
6.
Neuropsychiatric features of Parkinson's disease in the era prior to the use of dopaminergic therapies.
Cogn Neuropsychiatry
; 28(4): 243-252, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37170593
7.
Disrupted reward processing in Parkinson's disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysis.
J Neurol Neurosurg Psychiatry
; 93(5): 555-562, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930778
8.
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets.
J Clin Psychopharmacol
; 42(4): 400-404, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652731
9.
Towards safer risperidone prescribing in Alzheimer's disease.
Br J Psychiatry
; 218(5): 268-275, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33176899
10.
Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
Brain
; 143(12): 3842-3849, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188391
11.
First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study.
J Neurol Neurosurg Psychiatry
; 94(5): 403-405, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522155
12.
The Yale University Open Data Access Project: A Resource for Research in Psychopharmacology.
J Clin Psychopharmacol
; 43(5): 479-481, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683249
13.
Response to Letter to the Editors From Prof D. Taylor.
J Clin Psychopharmacol
; 43(1): 84-85, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36374191
14.
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
Brain
; 140(4): 1117-1127, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334978
15.
Reduced parahippocampal volume and psychosis symptoms in Alzheimer's disease.
Int J Geriatr Psychiatry
; 33(2): 389-395, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28741694
16.
Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).
Int J Geriatr Psychiatry
; 33(2): 396-404, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643852
17.
Very Late-Onset Schizophrenia-Like Psychosis: A Clinical Update.
J Psychosoc Nurs Ment Health Serv
; 56(1): 37-47, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28990640
18.
Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
Am J Geriatr Psychiatry
; 25(7): 708-716, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215900
19.
Cognitive phenotype of psychotic symptoms in Alzheimer's disease: evidence for impaired visuoperceptual function in the misidentification subtype.
Int J Geriatr Psychiatry
; 30(12): 1147-55, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809437
20.
Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
Int J Geriatr Psychiatry
; 29(10): 1001-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578318